Kenvue Inc. (KVUE) Free Cash Flow (FCF): $1.82B
The free cash flow (FCF) for Kenvue Inc. (KVUE) is $1.82B. It is above its 12-month average by 10.26% ($1.65B).
KVUE Free Cash Flow (FCF TTM) Chart
Rolling trailing-12-month free cash flow from quarterly statements; no daily interpolation.
KVUE Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 14 quarters.
KVUE Average Free Cash Flow (FCF) Chart
KVUE Current vs Average Free Cash Flow (FCF) Chart
KVUE Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$1.82B
FREE CASH FLOW (FCF) AVG TTM
$1.65B
FREE CASH FLOW (FCF) AVG 3Y
$1.93B
FREE CASH FLOW (FCF) AVG 5Y
N/A
FREE CASH FLOW (FCF) AVG 10Y
N/A
FREE CASH FLOW (FCF) AVG 15Y
N/A
FREE CASH FLOW (FCF) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.26%
CURRENT VS 3Y AVG
-5.74%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
FCF Analysis
Free Cash Flow (TTM)
$1.82B
FCF Yield
5.15%
Price/FCF
19.4
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Kenvue Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Kenvue Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for Kenvue Inc. (KVUE)?
- The free cash flow (FCF) for KVUE stock is $1.82B.
- What is the TTM average free cash flow (FCF) for Kenvue Inc. (KVUE)?
- The TTM average free cash flow (FCF) for KVUE stock is $1.65B.
- What is the 3Y average free cash flow (FCF) for Kenvue Inc. (KVUE)?
- The 3Y average free cash flow (FCF) for KVUE stock is $1.93B.
Kenvue Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2026-03-29 | $1.82B |
| 2025-12-28 | $1.72B |
| 2025-09-28 | $1.64B |
| 2025-06-29 | $1.63B |
| 2025-03-30 | $1.45B |
| 2024-12-31 | $1.33B |
| 2024-09-29 | $1.40B |
| 2024-06-30 | $1.77B |
| 2024-03-31 | $2.09B |
| 2023-12-31 | $2.70B |
| 2023-10-01 | $2.46B |
| 2023-06-30 | $2.53B |
| 2023-04-02 | $2.60B |
| 2023-01-01 | $2.15B |
| 2022-10-02 | $2.55B |
Related Metrics
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry